MedTrace Logo

A New Tool to Promote Patient's Engagement in Their Healthcare Process

NCT06762496 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2025-11-28

No results posted yet for this study

Summary

Women diagnosed with early-stage breast cancer need to make a decision about the therapeutic treatment to undertake. Since multiple factors can influence this decision, it is necessary to develop a decision-making support tool to assist them in making this choice.

Main Objective: To develop a decision-making support tool for determining the treatment to undertake for women diagnosed with early-stage breast cancer and test its effectiveness on an experimental group.

Conditions

  • Breast Carcinoma
  • Breast Cancer Stage I
  • Breast Cancer Stage II

Interventions

OTHER

Healthcare professionals

healthcare professionals (HCPs) targeted, including team members: we will involve 30 physicians (who are involved in the process of care towards patients with early breast cancer (10 oncologists, 10 breast surgeon, and 10 breast radiologists specifically) for the semi-structured interviews

OTHER

Patients PDA group

Participants will receive via mail the final version of the PDA and a Qualtrics link with a battery of questionnaires

OTHER

Patients control group

Participants will receive only the online link with the battery of questionnaires

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Gabriella Pravettoni · European Institute of Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-22
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06762496 on ClinicalTrials.gov